Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Calandra

Showing results (21-30 of 99) with videos related to

Pageof 10
Sort By:
The American Journal of Medicine|September 1, 1994
Bacteremia due to viridans streptococci in neutropenic patients: a reviewP Y Bochud, T Calandra, P Francioli
Trends in Microbiology|June 1, 1994
Macrophage migration inhibitory factor is a neuroendocrine mediator of endotoxaemiaJ Bernhagen, T Calandra, A Cerami, et al.
Diabetes/Metabolism Research and Reviews|July 9, 1999
A role for the endocrine and pro-inflammatory mediator MIF in the control of insulin secretion during stressG Waeber, T Calandra, C Bonny, et al.
Progress in Clinical and Biological Research|January 1, 1991
Anti-lipopolysaccharide and anti-tumor necrosis factor/cachectin antibodies for the treatment of gram-negative bacteremia and septic shockT Calandra, J D Baumgartner, M P Glauser
Intensive Care Medicine|April 20, 2001
Antibiotics in sepsisP Y Bochud, M P Glauser, T Calandra, et al.
Revue Medicale Suisse|June 27, 2008
[Empirical antibiotic therapy for febrile neutropenia]R Kridel, C Van Delden, T Calandra, et al.
Nature|January 10, 2002
MIF regulates innate immune responses through modulation of Toll-like receptor 4T Roger, J David, M P Glauser, et al.
The Journal of Infectious Diseases|August 1, 1988
Treatment of gram-negative septic shock with human IgG antibody to Escherichia coli J5: a prospective, double-blind, randomized trialT Calandra, M P Glauser, J Schellekens, et al.
The Journal of Experimental Medicine|June 1, 1994
The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factorT Calandra, J Bernhagen, R A Mitchell, et al.
The New England Journal of Medicine|April 28, 1994
Escherichia coli resistant to fluoroquinolones in patients with cancer and neutropeniaA Cometta, T Calandra, J Bille, et al.
Pageof 10

Showing results (21-30 of 99) with videos related to

Sort By:
Pageof 10
The American Journal of Medicine|September 1, 1994
Bacteremia due to viridans streptococci in neutropenic patients: a reviewP Y Bochud, T Calandra, P Francioli
Trends in Microbiology|June 1, 1994
Macrophage migration inhibitory factor is a neuroendocrine mediator of endotoxaemiaJ Bernhagen, T Calandra, A Cerami, et al.
Diabetes/Metabolism Research and Reviews|July 9, 1999
A role for the endocrine and pro-inflammatory mediator MIF in the control of insulin secretion during stressG Waeber, T Calandra, C Bonny, et al.
Progress in Clinical and Biological Research|January 1, 1991
Anti-lipopolysaccharide and anti-tumor necrosis factor/cachectin antibodies for the treatment of gram-negative bacteremia and septic shockT Calandra, J D Baumgartner, M P Glauser
Intensive Care Medicine|April 20, 2001
Antibiotics in sepsisP Y Bochud, M P Glauser, T Calandra, et al.
Revue Medicale Suisse|June 27, 2008
[Empirical antibiotic therapy for febrile neutropenia]R Kridel, C Van Delden, T Calandra, et al.
Nature|January 10, 2002
MIF regulates innate immune responses through modulation of Toll-like receptor 4T Roger, J David, M P Glauser, et al.
The Journal of Infectious Diseases|August 1, 1988
Treatment of gram-negative septic shock with human IgG antibody to Escherichia coli J5: a prospective, double-blind, randomized trialT Calandra, M P Glauser, J Schellekens, et al.
The Journal of Experimental Medicine|June 1, 1994
The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factorT Calandra, J Bernhagen, R A Mitchell, et al.
The New England Journal of Medicine|April 28, 1994
Escherichia coli resistant to fluoroquinolones in patients with cancer and neutropeniaA Cometta, T Calandra, J Bille, et al.
Pageof 10